ProShare Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $995K | Sell |
|
|||||
|
2025
Q1 | $1.23M | Sell |
|
|||||
|
2024
Q4 | $3.35M | Buy |
|
|||||
|
2024
Q3 | $3.33M | Buy |
|
|||||
|
2024
Q2 | $1.58M | Sell |
|
|||||
|
2024
Q1 | $1.82M | Buy |
|
|||||
|
2023
Q4 | $1.36M | Buy |
|
|||||
|
2023
Q3 | $934K | Buy |
|
|||||
|
2023
Q2 | $900K | Buy |
|
|||||
|
2023
Q1 | $524K | Sell |
|
|||||
|
2022
Q4 | $756K | Buy |
|
|||||
|
2022
Q3 | $262K | Buy |
|
|||||
|
2022
Q2 | $228K | Sell |
|
|||||
|
2022
Q1 | $334K | Sell |
|
|||||
|
2021
Q4 | $387K | Sell |
|
|||||
|
2021
Q3 | $414K | Sell |
|
|||||
|
2021
Q2 | $440K | Buy |
|
|||||
|
2021
Q1 | $292K | Buy |
|
|||||
|
2020
Q4 | $316K | Buy |
|